No Result

View All Result

No products in the cart.

2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑

Home StudyGraphics

#VisualAbstract Brief pembrolizumab monotherapy followed by doxorubicin, vinblastine, and dacarbazine was both effective and safe in untreated early unfavourable and advanced stage classical Hodgkin lymphoma

byKathleen Lau

March 25, 2021

in StudyGraphics

#VisualAbstract Brief pembrolizumab monotherapy followed by doxorubicin, vinblastine, and dacarbazine was both effective and safe in untreated early unfavourable and advanced stage classical Hodgkin lymphoma

#VisualAbstract: BRAF and MEK inhibitor combination therapy shows efficacy for advanced melanoma in Japanese patients

RelatedReports

Oncology

Daraxonrasib extends survival in metastatic pancreatic cancer

September 17, 2026

Cardiology

Borderline-low hemoglobin levels linked to increased mortality

September 14, 2026

Hematology

N-methylaniline exposure identified as likely cause of methemoglobinemia during maritime migration

September 13, 2026

Quick Take: Diagnostic Yield of One-Time Colonoscopy vs One-Time Flexible Sigmoidoscopy vs Multiple Rounds of Mailed Fecal Immunohistochemical Tests in Colorectal Cancer Screening

Chronic Disease

Molecularly guided therapy may improve outcomes in patients with unfavourable cancer of unknown primary compared with standard chemotherapy

September 7, 2026

Colchicine may lower the risk of cardiovascular events in patients with coronary disease

Non-obstructive lesions with high lipid content may increase risk for future adverse cardiac outcomes

Novel coronavirus identified from patients with pneumonia in Wuhan, China

Mechanics of SARS-CoV-2 spread in a sleep-away camp

Sleep duration, sleepiness, chronotype have variable associations with teen self-regulation

Poor sleep efficiency associated with major adverse cardiovascular events

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

No Result

View All Result

#VisualAbstract Brief pembrolizumab monotherapy followed by doxorubicin, vinblastine, and dacarbazine was both effective and safe in untreated early unfavourable and advanced stage classical Hodgkin lymphoma

Daraxonrasib extends survival in metastatic pancreatic cancer

Borderline-low hemoglobin levels linked to increased mortality

N-methylaniline exposure identified as likely cause of methemoglobinemia during maritime migration

#VisualAbstract: BRAF and MEK inhibitor combination therapy shows efficacy for advanced melanoma in Japanese patients

Non-obstructive lesions with high lipid content may increase risk for future adverse cardiac outcomes

RelatedReports

Daraxonrasib extends survival in metastatic pancreatic cancer

Borderline-low hemoglobin levels linked to increased mortality

N-methylaniline exposure identified as likely cause of methemoglobinemia during maritime migration

Molecularly guided therapy may improve outcomes in patients with unfavourable cancer of unknown primary compared with standard chemotherapy

Non-obstructive lesions with high lipid content may increase risk for future adverse cardiac outcomes

Mechanics of SARS-CoV-2 spread in a sleep-away camp

Poor sleep efficiency associated with major adverse cardiovascular events

2MM+ All Access

Recent Reports

The medical literature, distilled daily.

Membership benefits

#VisualAbstract Brief pembrolizumab monotherapy followed by doxorubicin, vinblastine, and dacarbazine was both effective and safe in untreated early unfavourable and advanced stage classical Hodgkin lymphoma

RELATED REPORTS

#VisualAbstract: BRAF and MEK inhibitor combination therapy shows efficacy for advanced melanoma in Japanese patients

Non-obstructive lesions with high lipid content may increase risk for future adverse cardiac outcomes

RelatedReports

2MM+ All Access

Recent Reports

The medical literature, distilled daily.

Membership benefits